Northwest Biotherapeutics | NWBO - Trade Creditors


Northwest Biotherapeutics reported 27.22M in Trade Creditors for its fiscal quarter ending in March of 2025.





Trade Creditors Change Date
Agenus USD 85.29M 10.89M Sep/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Celldex Therapeutics USD 4.27M 2.19M Sep/2025
Eisai JPY 85.49B 4.76B Dec/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Merck USD 4.15B 102M Sep/2025
Northwest Biotherapeutics 27.22M 5.8M Mar/2025
Pfizer USD 5.02B 142M Sep/2025
Plus Therapeutics 9.22M 2.07M Mar/2025
Roche Holding CHF 5.78B 1.27B Dec/2025